January 1, 2024 · Form 4 insider transaction
Balthaser Kevin sold 2,536 shares of Aclaris Therapeutics, Inc. at $1.05 per share, a transaction worth $2.7K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.